| 摘要: |
| 目的 基于网络药理学技术探索生脉注射液的体内药效物质基础和作用机制。方法 通过数据库及文献检索方法获取生脉注射液的有效成分,通过BATMAN-TCM构建的分子对接技术预测生脉注射液有效成分的体内作用靶标及相关通路,基于京都基因与基因组百科全书(KEGG)的通路富集分析功能,阐述生脉注射液的多成分-多通路作用机制。结果 通过上述方法共计发现295个有效成分,直接或间接涉及体内4 891个靶标,552种相关疾病。关键成分是,锦葵酸、腺苷、蝙蝠葛碱、维生素B12、十四醇、腺苷三磷酸肌醇。关键靶标是亚当金属肽酶结构域8、AKT丝氨酸/苏氨酸激酶1、ATP结合盒亚家族成员1、花生四烯酸15脂肪氧化酶、腺苷A1受体、缓激肽受体B2、一氧化氮合酶3、乙酰胆碱酯酶、丁酰胆碱酯酶。关键疾病是炎症反应、乳腺癌、心血管疾病、前列腺癌、哮喘、脓毒症、动脉粥样硬化、帕金森氏病、阿尔兹海默病、精神分裂症。涉及通路是糖酵解/糖异生、柠檬酸循环、磷酸戊糖途径、戊糖和葡糖醛酸盐相互转化、果糖与甘露糖代谢、半乳糖代谢、抗坏血酸与醛酸代谢、脂肪酸生物合成、脂肪酸伸长、脂肪酸降解。结论 生脉注射液主要通过多成分协同起效的机制起到抗炎、抗乳腺癌等疾病的作用。本研究结果初步验证了生脉注射液治疗疾病的有效成分和作用机制,为进一步深入揭示相关疾病的有效治疗方法开发奠定基础。 |
| 关键词: 网络药理学 生脉注射液 炎症反应 靶点 通路 |
| DOI:10.13506/j.cnki.jpr.2018.11.001 |
| 基金项目:国家自然科学基金面上项目(No.81673667) |
|
|
|
| Research on the functional mechanism of Shengmai Injection based on network pharmacology |
| WANG Tongjin1,ZHANG Yanhang2,LU Juan1,CHAI Ruiping1,CHEN Xi1 |
| (1.The Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College,Beijing 100193,China;2.Jiamusi No.1 High School,Jiamusi 154003,China) |
| Abstract: |
| Objective To explore the pharmacodynamic basis and mechanism of Shengmai injection in vivo based on network pharmacology. Methods The effective components of Shengmai Injection were obtained by database and literature search. The target of Shengmai Injection in vivo and It's related pathways were predicted by BATMAN-TCM molecular docking technique. Based on the pathway enrichment analysis function of Kyoto Encyclopedia Gene and Genome (KEGG), the Shengmai Injection was expounded with the mechanism of multicomponent-multichannel action. Results A total of 295 active ingredients were found by the above methods, which directly or indirectly involved 4 891 targets and 552 related diseases in vivo. The key ingredients were malolate, adenosine, dauricine, vitamin B12, tetradecanol and inositol adenosine triphosphate. The key targets were Adam metallopeptidase domain 8, AKT serine/threonine kinase 1, ATP binding cassette subfamily 1, arachidonate 15 lipase oxidase, adenosine A1 receptor, bradykinin receptor B2, nitric oxide synthase 3, acetylcholinesterase, and butyrylcholinesterase. The key diseases were inflammation, breast cancer, cardiovascular disease, prostate cancer, asthma, sepsis, atherosclerosis, Parkinson's disease, Alzheimer's disease, schizophrenia. The pathways involved were glycolysis/gluconeogenesis, citric acid cycle, pentose phosphate pathway, pentose and glucuronate conversion, fructose and mannose metabolism, galactose metabolism, ascorbic acid and aldehyde metabolism, fatty acid biosynthesis, fatty acid elongation, and fatty acid degradation.Conclusion Shengmai Injection played an anti-inflammatory and anti-breast cancer role mainly through the mechanism of multi-component synergy. The results of this study preliminarily verified the effective components and mechanism of Shengmai Injection, and laid a foundation for further revealing the effective treatment of related diseases. |
| Key words: Network pharmacology Shengmai Injection Inflammatory reaction Target Pathway |